HAMP and Tangier disease: Synthetic hepcidin mimetics such as PTG-300 or LJPC-401 have been reported to reduce serum iron levels and to be well-tolerated in phase 1 trials in healthy subjects and patients with iron overload, although the clinical relevance has still to be determined in ongoing studies (171, 172).